Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-26

Clinical Trial Update: Lithium in Inclusion Body Myositis (IBM)

View source ↗

Summary

This document reports the completion of a clinical trial evaluating lithium for Inclusion Body Myositis (IBM).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Phoenix Neurological Associates, LTD | Conditions: Inclusion Body Myositis | Status: COMPLETED